Find information on thousands of medical conditions and prescription drugs.

Nalbuphine

Nalbuphine (nalbuphine hydrochloride) is a synthetic opioid used commercially as an analgesic under a variety of trade names, including Nubain. It is noteworthy in part for the fact that at low dosages, it is found much more effective by women than by men, and may even increase pain in men.

Nalbuphine has been discontinued since 2003 in the UK.

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
Nabilone
Nadolol
Nafarelin
Nafcillin
Nalbuphine
Nalidixic acid
Nallpen
Naloxone
Naltrexone
Nandrolone
Naphazoline
Naprelan
Naprosyn
Naproxen
Naratriptan
Narcan
Nardil
Naropin
Nasacort
Nasalcrom
Nascobal
Natamycin
Navane
Navelbine
Nebcin
Nebracetam
Nefazodone
Nefiracetam
Nelfinavir
Nembutal
Neoarsphenamine
Neomycin
Neoral
Neosporin
Neulasta
Neupogen
Neurontin
Nevirapine
Nexium
Nialamide
Niaspan
Niclosamide
Nicoderm
Nicorette
Nicotinamide
Nicotine
Nicotinic acid
Nicotrol
Nifedipine
Nifehexal
Nikethamide
Nilstat
Nilutamide
Nimesulide
Nimodipine
Nimotop
Nitrazepam
Nitrofurantoin
Nix
Nizatidine
Nizoral
Nocodazole
Nolvadex
Nomifensine
Norco
Nordazepam
Nordette
Norepinephrine
Norethin
Norfloxacin
Norgestimate
Norgestrel
Norinyl
Noritate
Normodyne
Norplant
Norpramin
Nortriptyline
Norvasc
Norvir
Noscapine
Novafed
Novobiocin
Novocain
Novrad
Nuprin
Nysert
Nystaform
Nystatin
Nystex
Nystop
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Ondansetron relieves pruritus linked to spinal opioids - Cost a Major Drawback
From OB/GYN News, 7/1/03

PHOENIX,. ARIZ. -- Ondansetron has a dose-related prophylactic effect in relieving pruritus associated with spinal opioids administered for labor analgesia, Dr. Scott Segal said.

Patients who received 8 mg of ondansetron intravenously along with the standard intrathecal analgesic medication reported significantly milder itching than patients who received 2 or 4 mg ondansetron or a saline placebo, Dr. Segal reported at the annual meeting of the Society for Obstetric Anesthesia and Perinatology.

In a randomized double-blinded trial, Dr. Segal and his colleagues at Brigham and Women's Hospital in Boston assigned 40 women planning neuraxial analgesia for labor into four groups. Each patient received spinal analgesia consisting of 25 mg fentanyl plus 2.5 mg bupivacaine. At the same time, they were given intravenous injections of 2, 4, or 8 mg ondansetron or the placebo.

Pruritus and pain were assessed using a 100-mm visual analog scale at the time of the spinal injection and 5,15, 30, 60, and 90 minutes thereafter, Dr. Segal said. Patients were allowed to have 5 mg IV nalbuphine as a rescue medication at any time.

The pattern of pruritus was roughiy similar in all four groups, becoming noticeable within 5 minutes and reaching a peak at 30 minutes in the placebo and highest-dose groups, at about 55 mm and about 25 mm on the visual analog scale, respectively. Peak values in the groups receiving 2 and 4 mg ondansetron were recorded at the 60-minute reading, at approximately 40 mm and 43 mm, respectively.

Analgesia was the same in all four groups. None of the patients required the rescue medication.

Pruritus occurs in 60%-80% of women who receive spinal anesthesia, Dr. Segal said.

These findings suggest that 5-HT3 antagonists such as ondansetron may help relieve that itching, but they're not used routinely because they are very expensive--about $26 for an 8-mg dose at Brigham and Women's.

The fact that not even the patients in he placebo group required the rescue nedication suggests that pruritus is a time-limited problem that may best be treated with reassurance. Dr. Segal added that he now tells his patients that the itching begins to subside within about 30 minutes.

COPYRIGHT 2003 International Medical News Group
COPYRIGHT 2003 Gale Group

Return to Nalbuphine
Home Contact Resources Exchange Links ebay